Skip to main content

Medmen Enterprises Inc Class B Subordin (MMEN-CN) Quote

Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.370
Day High 1.420
Open:1.390
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
MedMen Enterprises Inc is the preeminent cannabis company with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Financial Institutions Take Note of Cannabis Market's Glowing Potential
- PR Newswire - Tue Nov 12, 8:00AM CST
PR Newswire - CMTX
Tue Nov 12, 8:00AM CST
The rapid emergence of the cannabis industry has finally caught Wall Street's attention as numerous analysts have initiated their coverage on the marketplace. Notably, firms such as RBC Capital Markets, Cowen, Piper Jaffray, and Bank of America Merrill Lynch have all realized the growth potential of the industry. For instance, Cowen analysts Vivian Azer, Brian Nicholas Velez, and Gerald Pasacarelli, see strong upside for the cannabis industry and forecast that U.S. cannabis sales are expected to reach USD 75 Billion by 2030. Specifically, Cowen points to a number of factors that will accelerate the marketplace, such as continued cannabis trial and use, lower levels of binge drinking, and cannabis being considered as a solution to opioids. On the other hand, RBC Capital Markets analyst Nik Modi believes that the cannabis industry is being propelled by the increasing recreational usage, particularly within the concentrates and edibles segments. Moreover, Modi believes that investments from public and private sectors such as the alcohol industry will also bolster the overall cannabis marketplace. However, Bank of America Merrill Lynch analyst Chris Carey predicts that Canada will reach oversupply by 2021 and views the oversupply, along with the ongoing U.S. legalization efforts, as major events expected to shift the market. As such, the collective insight from the analysts signals that the cannabis industry is continuing to expand. And according to data compiled by Zion Market Research, the global marijuana market was valued at approximately USD 16.71 Billion in 2017. By 2024, the market is expected to generate revenue of USD 62.96 Billion while growing at a CAGR of 21% from 2018 to 2024. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Tilray, Inc. (NASDAQ: TLRY), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Medmen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE)
Novel CBD-Based Products Capture the Attention of Discerning Consumers
- PR Newswire - Fri Nov 8, 8:00AM CST
PR Newswire - CMTX
Fri Nov 8, 8:00AM CST
As the cannabis industry continues growing, associations about the plant's use are rapidly beginning to change. Additionally, the way people consuming cannabis is also changing. While not as grand, cannabis flower sales still account for a large portion of total overall sales for most regions. For instance, Colorado was one of the first regions to fully legalize adult-use cannabis and during the first year of legalization in 2014, the state reported that flower controlled 67% of all cannabis sales. By 2018, Colorado witnessed its flower sales dwindle to 44%. However, during the same period, the market share of concentrates and extracts closed the gap, accounting for 31% of sales compared to 15% in 2014. And while the cannabis concentrate and extract market is rapidly becoming popular among consumers, other notable products such as tinctures, topicals, and edibles are also gaining a reputation. Specifically, these products are becoming more popular within the CBD marketplace because consumers are seeking new, innovative health and wellness products and are often part of the anti-pharma trend. As such, CBD-based tinctures dominate the market, driving 25% of sales. On the other hand, tinctures are slowly losing their market share as more consumer-friendly products enter the marketplace; Topicals (17% of the market) and skincare & beauty products (8%) have quickly become popular among mass retailers, pushing them into mainstream markets and into the eyes of consumers. And according to data compiled by Brightfield Group, the U.S. hemp-derived CBD market is expected to reach USD 23.7 Billion through 2023. Smart Decision, Inc. (OTC: SDEC), New Age Beverages Corporation (NASDAQ: NBEV), Medmen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH), Terra Tech Corp. (OTC: TRTC)
Edible CBD Products Offer Consumers a New Health Trend
- PR Newswire - Thu Oct 31, 8:00AM CDT
PR Newswire - CMTX
Thu Oct 31, 8:00AM CDT
Consumer trends constantly require industries to adapt in order to thrive among the competition. Specifically, the food and beverage industry is one of the fastest evolving markets because of constant changes in consumer demands. Nowadays, the increasing demand for healthier and more organic options is prompting manufacturers to produce alternatives to sugar-packed drinks and fatty snacks. Instead, consumers are looking for products that are processed with healthier sustainable ingredients, proteins, vitamins, and antioxidants. Notably, many consumers have turned to the beverage industry for functional drinks such as kombucha. A functional drink is a type of beverage that typically conveys a health benefit such as being packed with performance-enhancing agents like nootropics and amino acids. Consequently, the growing demand in the functional beverage market sparked interest within the CBD market. CBD is a derivative of the hemp plant, which falls under the cannabis family. Typically, cannabis is associated with its marijuana component, which causes psychoactive effects because of its heavy THC concentrate. However, hemp does not cause psychoactive effects because the main compound is CBD. THC and CBD are widely different in their biological makeup, but because they derive from the cannabis plant, regulators deemed both compounds to be unsafe for consumers. However, extensive research has uncovered that CBD provides therapeutic and health benefits, which then led to the rapid emergence of CBD-based products. As such, North American consumer spending on cannabis-infused foods and drinks reached USD 1.5 Billion in 2018, according to data compiled by Arcview Market Research and BDS Analytics, By 2022, the two firms suggest that edible sales are on track to reach USD 4.1 Billion. Newleaf Brands Inc. (OTC: NLBIF) (CSE: NLB), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Medmen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN), Liberty Health Sciences Inc. (OTC: LHSIF) (CSE: LHS), Terra Tech Corp. (OTC: TRTC)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.300 +5.38% increase
on 10/30/19
Period Open:1.580
Price movement based on the high, low and last over the given period.
1.870 -26.74% decrease
on 10/28/19
-0.210 (-13.29%) decrease
since 10/11/19
3-Month 1.300 +5.38% increase
on 10/30/19
Period Open:2.400
Price movement based on the high, low and last over the given period.
2.930 -53.24% decrease
on 08/13/19
-1.030 (-42.92%) decrease
since 08/12/19
52-Week 1.300 +5.38% increase
on 10/30/19
Period Open:6.310
Price movement based on the high, low and last over the given period.
6.480 -78.86% decrease
on 11/13/18
-4.940 (-78.29%) decrease
since 11/12/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).